Shi W - Search Results

1

Knockdown of ARK5 expression suppresses invasion of ovarian cancer cells.

Wang S, Li S, Wang H, Li W, Gao Y, Wang X, Fang C, Zhang B, Sun X, Li R, Shi W, Chen M, Shi L. Wang S, et al. Among authors: shi l, shi w. Mol Med Rep. 2019 Apr;19(4):2927-2934. doi: 10.3892/mmr.2019.9901. Epub 2019 Jan 28. Mol Med Rep. 2019. PMID: 30720082

2

Long non‑coding RNA DANCR promotes nasopharyngeal carcinoma cell proliferation and migration.

Hao Y, Zhao H, Jin X, He P, Zhang J, Dong Q, Shi W, Zhao M. Hao Y, et al. Among authors: shi w. Mol Med Rep. 2019 Apr;19(4):2883-2889. doi: 10.3892/mmr.2019.9906. Epub 2019 Jan 28. Mol Med Rep. 2019. PMID: 30720067

3

Ezetimibe inhibits the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT.

Kong L, He Q, Ma D, Shi W, Xin Q, Jiang C, Wu J. Kong L, et al. Among authors: shi w. FEBS Open Bio. 2024 May;14(5):831-842. doi: 10.1002/2211-5463.13797. Epub 2024 Mar 26. FEBS Open Bio. 2024. PMID: 38531630 Free PMC article.

4

PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.

Chen W, Wu J, Shi W, Zhang G, Chen X, Ji A, Wang Z, Wu J, Jiang C. Chen W, et al. Among authors: shi w. Cancer Sci. 2021 Jun;112(6):2158-2172. doi: 10.1111/cas.14853. Epub 2021 Apr 8. Cancer Sci. 2021. PMID: 33587761 Free PMC article.

5

UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.

Wu J, Xu X, Wu S, Shi W, Zhang G, Cao Y, Wang Z, Wu J, Jiang C. Wu J, et al. Among authors: shi w. Cancer Med. 2023 Sep;12(17):18078-18097. doi: 10.1002/cam4.6431. Epub 2023 Aug 10. Cancer Med. 2023. PMID: 37563971 Free PMC article.

6

Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity.

Ma D, Liu S, Hu L, He Q, Shi W, Yan D, Cao Y, Zhang G, Wang Z, Wu J, Jiang C. Ma D, et al. Among authors: shi w. J Cell Mol Med. 2021 Jul;25(14):7001-7012. doi: 10.1111/jcmm.16714. Epub 2021 Jun 16. J Cell Mol Med. 2021. PMID: 34137173 Free PMC article.

7

DEP Domain-Containing Protein 1B (DEPDC1B) Promotes Migration and Invasion in Pancreatic Cancer Through the Rac1/PAK1-LIMK1-Cofilin1 Signaling Pathway.

Zhang S, Shi W, Hu W, Ma D, Yan D, Yu K, Zhang G, Cao Y, Wu J, Jiang C, Wang Z. Zhang S, et al. Among authors: shi w. Onco Targets Ther. 2020 Feb 18;13:1481-1496. doi: 10.2147/OTT.S229055. eCollection 2020. Onco Targets Ther. 2020. PMID: 32110046 Free PMC article.

8

SphK2/S1P Promotes Metastasis of Triple-Negative Breast Cancer Through the PAK1/LIMK1/Cofilin1 Signaling Pathway.

Shi W, Ma D, Cao Y, Hu L, Liu S, Yan D, Zhang S, Zhang G, Wang Z, Wu J, Jiang C. Shi W, et al. Front Mol Biosci. 2021 Apr 22;8:598218. doi: 10.3389/fmolb.2021.598218. eCollection 2021. Front Mol Biosci. 2021. PMID: 33968977 Free PMC article.

9

Down-regulation of JCAD Expression Attenuates Cardiomyocyte Injury by Regulating the Wnt/β-Catenin Pathway.

Li C, Liu Z, Liu D, Jiang H, Bi C, Shi W. Li C, et al. Among authors: shi w. Folia Biol (Praha). 2024;70(4):229-238. doi: 10.14712/fb2024070040229. Folia Biol (Praha). 2024. PMID: 39692577 Free article.

10

EGFR bypass activation mediates acquired resistance to regorafenib in hepatocellular carcinoma.

Hu L, Shi W, Liu K, Ma D, Xin Q, Wang Z, Cao Y, Zhang G. Hu L, et al. Among authors: shi w. Front Med (Lausanne). 2024 Nov 13;11:1464610. doi: 10.3389/fmed.2024.1464610. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39606630 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,321 results

Search Page

Filters